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Abstract 
The longevity associated protein p66Shc has been suggested to regulate 
organismal lifespan through initiation of apoptotic pathways. Following stress-induced 
translocation into the mitochondria, p66Shc promotes increased reactive oxygen species 
(ROS) production and triggers poorly defined downstream signaling events that lead to 
decreased cell viability. Protein disulfide bonding has recently emerged as a ROS 
dependent post-translational modification that regulates protein function and signaling 
processes. Using the mouse hippocampal HT-22 cell line, I sought to determine the 
changes in the disulfide proteome associated with p66Shc mediated ROS production. 
Through Redox 2D-SDS PAGE analysis of mitochondrial and cytosolic extracts, redox 
sensitive proteins altered by p66Shc mediated ROS formation were identified. Of specific 
interest to this study, lamin B1 (LMNB1) and peroxidedoxin1 (PRXI) were identified as 
proteins that underwent an alteration in redox status and localization to the mitochondria 
in a p66Shc dependent manner. Furthermore, cytoskeletal proteins moesin, radixin 
tropomyosin-3 (TPM-3) and adenylate cyclase associated protein 1 (CAP1) were 
identified as undergoing changes in disulfide bonding in response to p66Shc mediated 
ROS production. The disulfide altered proteins identified in this study are generally 
associated with maintaining ROS balance and regulating cytoskeletal actin dynamics. 
Recent studies suggest these proteins may also acquire secondary roles involved in stress 
response and apoptotic pathways. My findings reveal that p66Shc elicits redox signaling 
events via ROS-dependent disulfide bonding of key antioxidant and cytoskeletal 
regulatory proteins which may affect apoptotic processes associated with organismal and 
cellular aging. 
Key Words: p66Shc, ROS, redox, apoptosis, disulfide bond. 
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Chapter 1 
Introduction  
 
1.1 Overview   
 
Aging is regarded as a natural biological process that occurs in all living 
organisms, however the cellular and molecular mechanisms underlying aging are not well 
understood. Cellular aging is associated with changes in gene expression, mutations, and 
elevated risk of apoptosis (Lombard et al., 2005). There is also evidence that the 
efficiency of cellular processes decrease over time, such that metabolism, protein 
function and oxygen by-products are altered as cells age (Sohal & Orr, 2012). The free 
radical theory of aging posits that there is increased formation of intracellular oxygen 
radicals primarily derived from mitochondria. This theory suggests that imperfections in 
the mitochondrial electron transport chain (ETC) during oxidative metabolism results in 
the formation and accumulation of partially reduced oxygen over time (Beckman & 
Ames, 1998). Partially reduced molecular oxygen can subsequently be converted to 
membrane permeable hydrogen peroxide, which can promote oxidative damage 
throughout the cell. It has been well documented that high levels of reactive oxygen 
species (ROS) are consistently associated with the activation of pro-apoptotic pathways   
(Giorgio et al., 2005; Sideris & Tokatlidis, 2010). Therefore, when studying aging at a 
cellular level, processes that potentially promote ROS formation are of particular interest.  
 
1.2 Reactive Oxygen Species 
     ROS consist of radical and non-radical oxygen species such as superoxide 
anion (O2-), hydrogen peroxide (H2O2) and hydrogen radical (HO•) (Ray, Huang, & 
T. Cann Thesis  2 
 
Tsuji, 2012). ROS are derived intracellularly from three main sources and serve a 
multitude of different purposes based on its levels. Two sources of ROS occur at the 
cytoplasmic membrane and are created by NADPH oxidases (NOXs) and 5-lipoxygenase. 
NOXs promote ROS formation in the cytoplasm when stimulated by integrins, cytokines, 
oncogenic Ras, and growth factors (Novo & Parola, 2008). NOXs create ROS during the 
metabolism of NADPH to NADP+ + H+ and the coupling of extracellular oxygen radicals 
with H+ molecules. In a similar manner, 5-lipoxygenase creates ROS through the creation 
of hydroperoxyeicosatetraenoic acid (HPETE) in a Ras dependent manner (Novo & 
Parola, 2008). The third and arguably most proficient source of intracellular ROS occurs 
from the mitochondria (Sena & Chandel, 2012).  
Mitochondrial derived ROS occur naturally as a by-product of oxidative 
phosphorylation, where oxygen is metabolized in a co-ordinated manner with the Krebs 
cycle to generate adenosine triphosphate (ATP) (Sena & Chandel, 2012). Mitochondrial 
derived ROS are considered the main source of intracellular ROS because oxidative 
phosphorylation is occurring constantly. The function of the ETC is to couple electron 
transfer between electron donors (NADH) and acceptors (O2), to the transfer of hydrogen 
ions across the inner mitochondrial membrane (through complex 1-4), thereby converting 
molecular oxygen (O2) to water (H2O) (Beckman & Ames, 1998). The resulting 
electrochemical gradient is utilized to generate energy in the form of ATP. The four ETC 
complexes along with cytochrome c channel electrons during oxidative phosphorylation 
to assist in the formation of water, however each electron exchange allows for potential 
electron leakage (Beckman & Ames, 1998).  
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To combat electron leakage, cells produce ROS scavenging proteins such as 
peroxidases, thioredoxins (TRXs), peroxiredoxins (PRXs), superoxide dismutases 
(SODs)  and other anti-oxidants located both in the mitochondria (i.e. PRXIII, MnSOD) 
and cytosol (i.e. Catalase, PRXI, TRX, SOD1) (Gertz, Fischer, Wolters, & Steegborn, 
2008; Nemoto & Finkel, 2002). These proteins function to detoxify high levels of ROS, 
while allowing a certain level of ROS to persist for various regulatory and signaling 
events (Nemoto & Finkel, 2002). However specific mechanisms controlling the 
physiological production of ROS, and the downstream signaling events affected by these 
oxidants, are poorly understood.  
 
1.3 Shc Protein Family and the p66Shc isoform 
     The Src homologous and collagen-like (Shc) family of proteins are generally 
characterized as adaptor proteins that participate in receptor tyrosine kinase-dependent 
activation of Ras in the cytoplasm (Rety et al., 1996). There are three main isoforms of 
Shc, each named in accordance to weight; p46Shc (46 kDa), p52Shc (52 kDa) and 
p66Shc (66 kDa) (Pelicci et al., 1992). Each Shc isoform is transcribed from the ShcA 
locus (mammals) where each Shc isoform is transcribed and differentially spliced (Wills 
& Jones, 2012). While p46Shc and p52Shc function as adaptor proteins for the Grb2 
complex and activation of the Ras signaling pathway, p66Shc has been shown to inhibit 
activation of the Ras/MAPkinase pathway triggered by the EGF and IGF-1 receptors 
(Trinei et al., 2009). This evidence suggests Shc proteins maintain a balanced equilibrium 
in regards to Ras pathway activity (Nemoto et al., 2006). 
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Common to all three Shc isoforms is a collagen homology domain (CH1) 
enriched in proline and glycine, a phosphotyrosine binding domain (PTB) and a Src 
homologous type 2 domain (SH2) at the C-terminus (Trinei et al., 2009). Unique to 
p66Shc is an additional collagen homology domain (CH2) at the N-terminus of the 
protein, which is not present in either the p46Shc or p52Shc isoforms. The Shc isoform 
p66Shc has been shown to serve multiple functions depending on its phosphorylation 
status and localization (Trinei et al., 2009). p66Shc is a protein that promotes increased 
intracellular ROS production and affects longevity in mice (Di Lisa, Kaludercic, Carpi, 
Menabo, & Giorgio, 2009). Previous research using p66Shc knockout mice (-/-) have 
shown significantly decreased intracellular ROS levels and increased longevity of up to 
30% compared to control wild-type mice (Migliaccio et al., 1999). Following exposure to 
cellular stress (i.e. H2O2 or UV), the p66Shc isoform has been shown to translocate into 
the intermembrane space (IMS) of mitochondria (Pinton & Rizzuto, 2008). The 
additional CH2 domain found in the p66Shc is necessary for its translocation into the 
mitochondria; an event necessary for increased ROS production (Gertz et al., 2008). 
Protein Kinase C-β (PKC-β) actively phosphorylates p66Shc at serine position 36 in 
response to a cellular stress. Serine phosphorylation at position 36 ultimately promotes 
association with Pin1, subsequent isomerization of a phosphor-Ser36-Pro37 bond and 
initiates the mitochondrial translocation event (Gertz et al., 2008; Pinton & Rizzuto, 
2008). 
Once present in the mitochondria, the specific physical activity of p66Shc is 
relatively unclear, however p66Shc has been shown to increase mitochondrial ROS by 
directly increasing ROS production, and also impairing ROS response mechanisms 
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(Nemoto & Finkel, 2002). Expression and activity of the ROS scavenger Mitochondrial 
Superoxide Dismutase (MnSOD) is impaired by p66Shc (Pani, Koch, & Galeotti, 2009). 
The subsequent increase of ROS can diffuse into the cytosol and inactivate FOXO 
transcription factors through phosphorylation by the AKT pathway (Song, Ouyang, & 
Bao, 2005). FOXO transcription factors induce MnSOD and catalase activity, therefore 
p66Shc mediated repression of MnSOD activity combined with inactivation of FOXO 
transcription factors within the cytosol by diffused ROS creates a positive feed-forward 
loop amplifying the oxidative cascade created by p66Shc (Pani et al., 2009).  
Upon translocation into the mitochondrial IMS, p66Shc promotes the formation 
of mitochondrial ROS through direct/indirect interactions with the ETC (Giorgio et al., 
2005). Within the IMS, p66Shc is suggested to mediate electron transfer from 
cytochrome c to oxygen, by virtue of its cytochrome c binding domain, and promote 
increased O2•- formation. O2•- is subsequently converted to hydrogen peroxide (H2O2) by 
SOD1. The physical accumulation of p66Shc and associated H2O2 production within the 
IMS could potentially upset the balance of redox sensitive proteins involved in electron 
transport and ROS maintenance. Furthermore, the presence of p66Shc within the IMS 
could catalyze widespread changes to the disulfide proteome within the mitochondria and 
initiate a stress response, opening of a mitochondrial permeability transition pore and the 
release of apoptotic factors into the cytosol (Sideris & Tokatlidis, 2010; Sohal & Orr, 
2012). The increased levels of membrane permeable H2O2 associated with p66Shc 
localization to the mitochondria may also affect redox sensitive proteins located further 
downstream within the cytosol, leading to widespread changes in the cytoplasmic 
disulfide proteome (Figure 1) (Cumming et al., 2004).  Therefore, assessing the disulfide 
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proteome of the mitochondria and cytosol individually may help elucidate the precise 
function of p66Shc. 
 
1.4 Regulatory Mechanisms of Protein Disulfide Bonds 
    Recent studies have shown that changes in protein DSBs can affect cell signaling 
with some specificity (Gertz et al., 2008). The importance of protein disulfide bonds was 
first noted in 1961 by Anfinsen and Haber, which helped illustrate the importance of 
DSBs for protein stability and function (Anfinsen & Haber, 1961). Disulfide bond 
formation predominantly occurs in the oxidizing environment of the endoplasmic 
reticulum, which permits the formation of DSBs in a controlled manner (Cumming et al., 
2004). Most protein cysteine residues have a pKa > 8.0, causing them to remain 
protonated in reducing environments, such as the cytoplasm and nucleus. However, there 
is a small group of redox-sensitive proteins, which contain cysteine amino acid residues 
that exist as thiolate anions (Cys-S-) at physiological pH (7.2 pKa). This occurs as a result 
of a lowering of pKa values by charge interactions with neighbouring amino acid residues 
(Cumming et al., 2004). Cysteine residues that exist as thiolate anions at physiological 
pH have been found to undergo disulfide bonding in the cytosol and nucleus under both 
oxidative and non-oxidative conditions (Cumming et al., 2004). Various proteins can 
promote DSB formation such as redox-dependent receptors (Mia40) and sulfhydryl 
oxidases (Erv1) (Sideris & Tokatlidis, 2010). Both Mia40 and Erv1 are present in the 
mitochondrial IMS and research has suggested their involvement in DSB formation 
during the potentially oxidizing conditions of the mitochondrial environment (Nemoto & 
Finkel, 2002; Sideris & Tokatlidis, 2010).  
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Numerous proteins have recently been identified as undergoing reversible protein 
DSB formation as a regulatory mechanism (Gertz et al., 2008). Proteins such as the proto-
oncogene tyrosine-protein kinase Src and other tyrosine kinases can be inactivated by 
ROS induced disulfide bonding (Cys-S-S-Cys) (Inaba, 2010; Rety et al., 1996). Well-
characterized redox sensitive proteins like Src exhibit changes in activity related to DSB 
formation and possess conserved sequences that are shared among homologous proteins 
(Gertz et al., 2008). It stands to reason that conserved sequences within a redox sensitive 
protein shared among multiple proteins may provide clues about the redox-regulated 
activity of those protein families. For the purposes of the research described here, p66Shc 
and its influence on the disulfide proteome is of particular interest.  
Disulfide bonding of p66Shc may allow translocation of the protein into the 
mitochondria by altering its conformation. Once translocated into the mitochondrial IMS, 
p66Shc is believed to promote ROS formation, possibly through inter- or intra-molecular 
DSB interactions with native proteins (Pinton & Rizzuto, 2008). The exact activity of 
p66Shc within the mitochondrial IMS has yet to be conclusively determined, however the 
well documented increase in mitochondrial ROS production associated with p66Shc 
mitochondrial translocation may lead to indirect changes to the disulfide proteome in 
other cellular compartments. Similarly, proteins within the cytosol and other subcellular 
locations can be affected by ROS-induced formation of disulfide bonds within kinases, 
phosphatases, antioxidant proteins and structural proteins (Paulsen & Carroll, 2010). 
Changes identified in these downstream proteins may provide clues about how p66Shc 
expression affects cellular longevity. 
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1.5 Cell Stress Responses and Rationale 
A number of studies have provided valuable evidence concerning the detrimental 
role of increased H2O2 production and the potential downstream effects of p66Shc-
mediated ROS on protein phosphorylation and gene expression (Carpi et al., 2009). 
p66Shc mediated ROS production can affect cells by triggering either cell survival 
responses, cell stress responses or potentially apoptotic responses (Migliaccio et al., 
1999). The particular defense system a cell mounts against increased cellular stress 
depends heavily on the best chance for survival (Fulda, Gorman, Hori, & Samali, 2010). 
There are several known stress response mechanisms and pathways such as heat shock 
response, unfolded protein response and DNA damage response. These responses 
function to regulate cell death in response to cell injuries administered by specific stresses 
(Samali, Fulda, Gorman, Hori, & Srinivasula, 2010).  However, the increase in p66Shc 
mediated ROS associated with p66Shc serine phosphorylation has been suggested to 
activate an oxidative stress response (Fulda et al., 2010). 
Previous studies suggest a close relationship between increased intracellular ROS 
levels and apoptosis (Fulda et al., 2010; Sohal & Orr, 2012). Upon recognition of rising 
ROS levels, or following a disruption in the ability to reduce ROS levels, an oxidative 
stress response is initiated for cell survival (Rabilloud, Chevallet, Luche, & Leize-
Wagner, 2005). As previously stated, a main contributor of intracellular ROS production 
occurs through inefficient electron transport from the ETC. However, the exact site of 
ROS production may not be as important for initiating a stress response but rather redox 
specific signaling further downstream may trigger a stress response (Sohal & Orr, 2012).  
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Situations where high levels of ROS are produced generally lead to loss of 
mitochondrial membrane potential (∆Ψm), the release of cytochrome C from the 
mitochondria to the cytosol and activation of the apoptotic pathway (Di Lisa et al., 2009). 
Apoptosis triggered by mitochondrial-derived ROS may be regulated by any number of 
stress receptors, potentially located in the mitochondria, nucleus or cytosol (Fulda et al., 
2010; Sato et al., 2009). Therefore it is imperative to examine redox modifications of 
proteins in different subcellular locations. Specifically, comparing alterations in the DSB 
status of mitochondrial versus cytosolic proteins may provide better clues to downstream 
effectors of p66Shc-signaling. 
 
1.6 Hypothesis and Research Outline 
 I hypothesize that ectopic expression and chemical activation of p66Shc in 
the mouse hippocampal cell line (HT-22) will promote increased mitochondrial ROS 
production and lead to altered disulfide bonding of proteins within the 
mitochondrial and cytosolic compartments. Changes in disulfide bonding of specific 
proteins may mediate some of the downstream signaling events associated with 
p66Shc activation. 
 By expressing an HA-tagged p66Shc expression vector in HT-22 cells, this 
research intends to assess the effects of p66Shc activation on the disulfide proteome 
within mitochondrial and cytosolic subcellular compartments. A PKC-β agonist 
(DOPPA) will be used to induce serine-36 phosphorylation of p66Shc, promoting its 
translocation into the mitochondria. Experiments will be performed to determine if 
ectopic p66Shc expression and DOPPA induced serine phosphorylation will (a) produce 
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increased ROS levels and lead to decreased cell viability and (b) alter the disulfide 
proteome of mitochondrial and cytosolic fractions compared to control (pcDNA) 
transfected cells following analysis by two-dimensional (2D) redox polyacrylamide gel 
electrophoresis (PAGE) analysis. Disulfide bonded proteins (DSBPs) reproducibly 
affected by p66Shc activation will be identified by mass spectrometry. This research aims 
to establish the effects of p66Shc expression and serine phosphorylation on the disulfide 
proteome within the mitochondrial and cytosolic compartments. Alterations detected in 
the subcellular disulfide proteome may reveal novel mechanisms of p66Shc stress 
response activation and initiation of apoptotic pathways.  
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Figure 1. Model of p66Shc mediated mitochondrial ROS production. Under control 
conditions, p66Shc localizes to the plasma membrane until cellular stress triggers PKC-β 
activation and phosphorylation of p66Shc on the serine amino acid residue located at 
position 36 within the CH2 domain. This phosphorylation event causes peptidyl-prolyl 
cis-trans isomerase NIMA-interacting 1 (Pin1) to associate and promote isomerization of 
a phosphor-Ser36-Pro37 bond in p66Shc thereby allowing it to translocate into the 
mitochondrial intermembrane space (IMS). The role of p66Shc within the mitochondrial 
IMS is poorly defined, however it is believed that p66Shc mediates electron transfer from 
cytochrome C to oxygen by virtue of its cytochrome C binding domain and promotes 
increased superoxide (O2¯ ) formation. O2¯  is converted to hydrogen peroxide (H2O2) by 
SOD1. Increased mitochondrial H2O2 may oxidize proteins within the mitochondrial IMS 
that may be associated with electron transport during oxidative phosphorylation, further 
accelerating the release of oxygen radicals as part of a positive forward-feed loop 
mechanism. H2O2 may also diffuse into the cytosolic domain of the cell and initiate 
changes to redox-sensitive proteins which participate in signaling processes.  Note: 
Adapted from “p66Shc Signals to Age” (Trinei et al., 2009).  
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Chapter 2 
Materials and Methods 
 
2.1 Cell Culture Conditions 
The immortalized mouse hippocampal cell line HT-22 was provided by Dr. David 
Schubert, The Salk Institute, LaJolla, CA. HT-22 cells were chosen because they are 
neuronal in origin, and many studies have suggested mitochondrial dysfunction and 
increased ROS levels in the CNS correlates with aging and neurodegeneration (Beckman 
& Ames, 1998; Su et al. 2012). Cells were cultured in Dulbecco’s Modified Eagles 
Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin. Cells were incubated at 37°C in a CO2 incubator with 5% 
CO2/95% humidified air atmosphere and maintained at a maximum density of no more 
than 85% confluency. 
 
2.2 HA-tagged p66Shc Vector Construction 
A human pcDNA-p66Shc wild-type vector template was generously provided by 
Dr. Mauro Cozzolino, Fondazione Santa Lucia IRCSS, Rome, Italy. The p66Shc 
expression construct was sequenced (DNA Sequencing Facility, Robarts Research 
Institute, London, Onario) to determine accuracy of the sequence before proceeding with 
further molecular work. Once p66Shc sequence accuracy was determined, the p66Shc 
vector was used as a template to create and amplify a HA-tagged p66Shc isoform using a 
Polymerase Chain Reaction (PCR)-based strategy (Invitrogen, Burlington, Ontario, 
Canada) supplemented with Dimethyl Sulfoxide (DMSO) to inhibit the formation of 
secondary or tertiary structures during the reaction. The forward primer sequence was 5’- 
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GACGATAGTCCGACTACCCTGTGT – 3’ and the reverse primer sequence was 5’ – 
ACTCTAGATTAAGCGTAGTCTGGGACGTCGTATGGGTACAGTTTCCGCTCCAC
AGG – 3’. The amplified HA-tagged p66Shc sequence was then digested using the 
restriction enzymes EcoRI and XbaI (Invitrogen Canada) as these restriction sites had 
been incorporated into the 5’ and 3’ PCR primers respectively. The digested PCR product 
was then ligated into a pcDNA3.1 vector previously digested with EcoRI and XbaI and 
incorporation of the PCR product was confirmed by sequencing (Robarts DNA 
Sequencing Lab, London, Ontario, Canada).  
 
2.3 Transfection and activation of HA-tagged p66Shc   
Depending on the requirements of the experiment, HT-22 cells were seeded at 5 x 
105 in a 100 mm cell culture dish or 3 x 105 in a 60 mm cell culture dish (BD Biosciences 
Canada). Cells were transiently transfected with either an empty pcDNA3.1 vector 
(control) or the p66Shc-HA expression plasmid.  Briefly, 5 µg p66Shc-HA DNA was 
combined with 8 µl of Lipofectamine 2000 (Invitrogen) in 1 mL of Opti-MEM 
transfection media (Invitrogen) and added to HT22 cells then placed in a 37°C CO2 
incubator (5% CO2, 95% O2) for 5 hours.  In a pilot experiment, transfection efficiency 
was confirmed by co-transfecting pGFP with p66Shc (1:3 ratio), to ensure that at least 
50% of the cells were expressing GFP.  p66Shc requires phosphorylation at the serine 
amino acid residue located at position 36 by PKC-β to become activated (Trinei et al., 
2009). This phosphorylation event occurs following exposure to stressors such as H2O2 or 
UV light. However, taking into consideration that introducing HT-22 cells to those types 
of stresses may cause changes to the disulfide proteome irrespective of p66Shc activation, 
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a more specific agonist of PKC-β was required. Previous studies have suggested that 12-
deoxyphorbol 13-phenylacetate 20-acetate (DOPPA) (Sigma-Aldrich, Oakville, Ontario, 
Canada), a PKC-β agonist, may be able to initiate PKC-β in a much more specific manner 
than treatment with H2O2 or UV (Ryves, Evans, Olivier, Parker, & Evans, 1991). DOPPA 
is a phorbol ester that works in concert with diacylglycerol to activate PKC-β by 
disrupting the association of an inhibitory pseudosubstrate (Gschwendt, Kittstein & 
Marks, 1991).  Empirical experimentation determined that a treatment of 50 nM DOPPA 
for 6 hours was the optimal concentration and exposure time for p66Shc-HA 
phosphorylation (Figure 3A and B).  Following transfection, cells were placed back in 
serum supplemented DMEM where they remained untreated (control) or exposed to 50 
nM DOPPA for 6 or 12 hours as required. 
 
2.4 Conventional SDS PAGE and Immunoblot Analysis 
Once transfection and appropriate treatment was completed, cells were washed 
using Phosphate Buffered Saline (PBS) (VWR Canada), then harvested using a 1% 
Triton-X lysis buffer (50 mM Tris pH 7.5 (Sigma-Aldrich), 1% Triton-X (Sigma-
Aldrich), 40 mM Iodoacetimide (IA) (Sigma-Aldrich), 1mM 
phenylmethanesulfonylfluoride (Sigma-Aldrich), 50 mM Sodium Fluoride (NaF) (Sigma-
Aldrich) and 10mM Sodium Orthovanodate (Na3VO4) (Sigma-Adrich). Protein 
concentrations of the lysates were quantified using a colourimetric DC Protein Assay Kit 
(BioRad, Hercules CA).  
Protein extracts (20-30 µg) were reduced in loading buffer containing 100 mM 
dithiothreitol (DTT) and 2% beta mercaptoethanol (BME), boiled and resolved by SDS-
T. Cann Thesis  16 
 
PAGE (12%) using a Mini-PROTEAN electrophoresis apparatus (BioRad Canada, 
Mississauga, ON). Proteins were then transferred from the gel onto polyvinylidene 
fluoride (PVDF) membrane (Millipore, Bedford, MA) by electroblotting, and blocked 
with 2% bovine serum albumin and 2% milk in tris-buffered saline with Tween-20, pH 
7.5 (TBS-T). Membranes were then probed with one of the following antibodies: mouse 
Anti-Total Shc (BD Transduction Laboratories, Mississauga, ON), monoclonal mouse 
Anti β-actin (Sigma-Aldrich), mouse anti-Phosphorylated-p66Shc (Calbiochem, San 
Diego, CA), mouse anti-Voltage Dependent Anion Channel (VDAC) (Cell Signaling, 
Danvers MA), monoclonal mouse anti-HA (Covance, Berkeley, California) and  anti 
tropomyosin-3 (Genetex, Irvine, CA).  
After overnight incubation, membranes were washed for 3 x 10 minutes in TBS-T 
and incubated in goat-anti-mouse horseradish-peroxidase conjugated secondary antibody 
(Jackson ImmunoResearch, West Grove, PA) for 2 hours. Following incubation, 
membranes were again washed 3 x 10 minutes in TBS-T, and developed using Pierce 
ECL Western blotting reagents (Thermoscientific, Waltham, MA), and protein signal was 
detected using a ChemiDoc digital imaging system (BioRad Canada). 
 
2.5 Mitochondrial ROS analysis 
To measure mitochondrial ROS production, cells were seeded at a density of 1 x 
105 cells in six 35 mm plates. After 24 hours, cells on three of the plates were transiently 
transfected with an empty pcDNA3.1 expression vector, and the other three were 
transiently transfected with the p66Shc-HA overexpression construct. Each pair of 
transfected cells (i.e. one pcDNA3.1 and one p66Shc-HA per pair) were subjected to 
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varying time lengths of 50 nM DOPPA exposure (No treatment, 6 hours, 12 hours) to 
determine optimal changes in mitochondrial ROS levels. After transfection and 
appropriate treatment, media was replaced with serum-free DMEM containing 200 nM 
MitoTracker® Red CM-H2XRos (Invitrogen Canada) and incubated for 30 min. Cells 
were then washed twice with warm phenol red-free DMEM, followed by incubation in  
phenol red-free DMEM with 10 ug/ml Hoescht (Sigma-Aldrich) for 3 minutes at 37°C to 
stain for nuclei. Cells were then washed again in phenol red-free DMEM and visualized 
using a fluorescent microscope (Zeiss AxioObserver, 40X objective). Four images from 
randomly selected regions were taken from each different treatment using a Q Imaging 
camera and Q Capture Pro Software. The fluorescent intensity of each image was later 
quantified using Image J software. Images of MitoTracker® Red CM-H2XRos stained 
cells and Hoescht stained nuclei were merged to create figures. 
 
2.6 Trypan Blue Exclusion Test 
The effects of p66Shc-HA overexpression on HT-22 cell viability were 
determined using a trypan blue (VWR Canada) dye exclusion test. HT-22 cells were 
seeded at a density of 1 x 104 in triplicate in 2 – 12 well dishes. Cells were then 
transiently transfected with either 0.5 µg pcDNA3.1 (control) or 0.5 µg p66Shc-HA for 5 
hours using Lipofectamine 2000 (Invitrogen Canada). After 5 hours, Opti-MEM media 
was replaced with the serum supplemented DMEM media. After 24 hours, cells were 
treated with DOPPA (50 nM) in DMEM and incubated for 6, 12 or 24 hours. At the end 
of each treatment, cells were collected using 100 µl of TrypLE Express (Invitrogen 
Canada) and incubated for 5 min at 37°C. Once the cells had detached, 100 µl of Trypan 
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Blue was added to the appropriate well, mixed, and loaded into a haemocytometer for 
counting. Cells that excluded trypan blue staining were counted as viable cells. Cell 
viability was calculated as a percentage based on the number of viable cells versus total 
number of cells in each treatment. 
 
2.7 HT-22 Subcellular Fractionation and Mitochondrial Isolation 
For each experimental treatment (pcDNA3.1, p66Shc-HA, pcDNA3.1+DOPPA 
(50 nM), p66Shc-HA+DOPPA (50 nM)) cells were seeded on eight 100 mm plates at a 
density of 5 x 105 cells per plate. Cells were transiently transfected as previously 
described and half the cells were treated with DOPPA (50 nM) for 12 hours. Cells were 
then centrifuged at 400 x g for 5 min, washed and resuspended using 1 ml warm PBS, 
then transferred to a 1.5 ml microfuge tube (VWR Canada) and pelleted again. A 
mitochondrial isolation kit (ThermoScientific,Waltham, MA) was used to fractionate the 
mitochondria using a series of kit-specific buffers and centrifuge spins according to the 
manufacturer’s instructions. Once cytosolic and mitochondrial fractions were isolated, a 
1% Triton-X lysis buffer was added to the mitochondrial fraction, and lysed mechanically 
by repeatedly pipetting the solution rapidly. Cytosolic and mitochondrial fractions were 
then prepared accordingly for either redox 2-D PAGE or reduced/non-reduced 1-D PAGE 
analysis.  
 
2.8 Redox 2D SDS PAGE Analysis 
    Protein extracts from subcellular fractions were quantified by a colorimetric DC 
Protein Assay Kit (BioRad). Once quantified, protein samples (150 – 200 µg of Triton-X 
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lysate) were resolved through a 1.5 mm, 12% acrylamide gel for 16 hours at constant 
current. Gel strips were then cut and soaked in a SDS loading buffer (0.5M Tris-HCl, 5% 
glycerol, 2% SDS) containing 100 mM DTT for 20 min at room temperature. The gel 
strips were then rinsed twice with SDS running buffer and soaked in SDS loading buffer 
containing 40 mM IA for 10 min at room temperature to alkylate newly exposed thiol 
groups. Gel strips were then rinsed again 2 X in SDS running buffer and individual lanes 
containing each protein samples were cut to a width of approximately 5 mm wide then 
loaded horizontally into a second 1.5 mm, 12 % acrylamide gel and resolved for 16 hours 
at constant current. The resulting 2D gels were then fixed in 50% methanol overnight.  
 
2.9 Silver Staining of Redox 2D Gels   
         Following methanol fixation, the gels were washed 3 X 20 min in H2O, and then 
sensitized in 0.02% sodium thiosulfate for 90 sec, immediately followed by 3 X 30 sec 
washes in H2O. Gels were then stained with 0.1% silver nitrate for 30 min at room 
temperature, washed 3 X 1 min in H2O and developed in 2% sodium carbonate, 0.0185% 
formaldehyde, and 0.0004% sodium thiosulfate. Gels were developed for approximately 
10 min or until appropriate stain intensity was reached. Stain development was stopped 
using 6% acetic acid. Gels were then analyzed, and experimental gels (p66Shc-HA 
transfected) were compared to control gels to establish visual changes in DSBPs. 
 
2.10 Identification of Redox Sensitive Proteins 
DSBPs that were altered in a p66Shc-dependent manner were picked with an 
automated spot picker and digested in-gel using a MassPREP automated digester station 
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(ParkinElmer, Waltham MA). Silver stained gel pieces were de-stained using a 50 mM 
sodium thiosulfate and 15 mM potassium ferricyanide solution, followed by protein 
reduction using 10 mM DTT, alkylation using 55 mM IA, and tryptic digestion. Peptide 
extraction was completed using a formic acid (1%), acetonitrile (2%) solution, after 
which peptides were lyophilized. Peptide samples were then re-dissolved in a 10% 
acetonitrile, 0.1% trifluoracetic acid solution, and then mixed 1:1 (v/v) with MALDI 
matrix (α-cyano-4-hydroxycinnamic acid), prepared as 5 mg/mL in 6 mM ammonium 
phosphate monobasic, 50% acetonitrile, 0.1% trifloracetic acid). Digested protein 
samples were identified using a 4700 Proteomics Analyzer MALDI TOF (Applied 
Biosystems, Foster City, CA) equipped with a 355 nm Nd:YAG laser. Data acquisition 
and processing were accomplished using the 4000 Series Explorer and Data Explorer, 
respectively (both from Applied Biosystems). Reflection (positive and negative) ion 
mode was used and the instrument was calibrated at 50 ppm mass tolerance, with each 
mass spectrum collected as a sum of 1000 shots. Identities of the isolated disulfide linked 
proteins were determined through NCBI rodent (Mus musculus) protein database 
searches. 
 
2.11 TRITC-Phalloidin Immunostaining of Actin Filaments 
In a 12 well dish, cells were seeded at a density of 1 X 105 on coverslips that had 
previously been treated with polylysine (Invitrogen Canada) to ensure proper cell 
adherence. After 24 hours, media was removed and cells were transiently transfected with 
pcDNA3.1 (control) and p66Shc-HA using Opti-MEM media and Lipofectamine for 5 
hours as previously described. Following transfection, the Opti-MEM media was 
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aspirated and serum supplemented DMEM containing 50 nM DOPPA was added to 
designated wells for a 6 or 12 hour treatment. Upon completion of DOPPA treatment, 
each well was aspirated and washed 2 X with 37°C PBS, then fixed in 4% 
Paraformaldehyde in PBS for 10 min. Cells were then blocked using 1% BSA in PBS for 
30 min to prevent any non-specific binding. Each coverslip was then stained with 30 µl of 
TRITC-Phalloidin (5 ug/ml in PBS with 1% BSA) for 20 min. Following TRITC-
Phalloidin staining, nuclei were stained by incubating coverslips in 50 µg/mL Hoescht 
33342 (Sigma-Aldrich) for 3 min. Coverslips were then washed 2 X in cold PBS and 
mounted on slides using Prolong Gold Antifade mounting media (Invitrogen). Stained 
cells were visualized using a fluorescent microscope (Zeiss AxioObserver, 40X 
objective). 
 
2.12 Nonreducing/Reducing 1D SDS PAGE 
      Samples used for nonreducing/reducing 1D SDS PAGE were collected as 
previously described for conventional 1D SDS PAGE analysis. However, half of the 
sample was allocated and prepared separately, such that it was not exposed to reducing 
agents (BME or DTT) and extra caution was taken to avoid heat, thereby preserving 
disulfide bonds. The other half of the original sample was exposed to reducing agents and 
boiled for 5 min. The samples were then resolved in a 12% acrylamide mini-gel (BioRad) 
and proteins transferred onto a PVDF membrane where they were further probed for 
specific proteins and visualized by a ChemiDoc digital imaging system (BioRad) as 
described above. 
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2.13 Statistical Analysis 
 Statistical analysis of MitoTracker® Red CM-H2XRos data measuring 
mitochondrial ROS and trypan blue exclusion test data measuring cell viability data was 
performed using One-way ANOVA analysis.  Comparisons of ROS production and 
percentage cell viability were performed using Post-hoc TUKEY tests. P-values of <0.05 
were considered to be significant.  
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Chapter 3 
Results 
 
3.1 Production and expression of HA-tagged p66Shc overexpression construct 
 A pcDNA3.1 expression vector containing wildtype non-tagged p66Shc cDNA 
was obtained and used as a template for the generation of a HA-tagged p66Shc 
expression insert using a PCR strategy. Upon completion of the p66Shc-HA expression 
construct, sequencing was performed to ensure that the p66Shc and HA tag sequences 
were correctly incorporated. HT-22 cells were transfected with the non-tagged and HA-
tagged p66Shc expression constructs and whole cell extracts were analyzed by Western 
blotting using an antibody that recognizes all Shc isoforms (Figure 2). Cells transfected 
with the control pcDNA3.1 plasmid exhibited no detectable expression of endogenous 
p66Shc. Interestingly, cells transfected with the HA-tagged p66Shc plasmid exhibited the 
highest levels of ectopic expression compared to cells transfected with the non-tagged 
version. In addition, following the reprobing of the blot with an anti-HA antibody, a ~66 
kDa band was detected only in cells transfected with the HA-tagged p66Shc-tagged 
vector.   
 
3.2 Phosphorylation of p66Shc using the PKC-β agonist DOPPA 
 Cytosolic p66Shc requires an additional phosphorylation event at serine 36 to 
initiate mitochondrial translocation (Gertz et al., 2008). To achieve site-specific 
phosphorylation, a PKC-β agonist (DOPPA) was employed as PKC-β has been shown to 
trigger phosphorylation of serine-36 in p66Shc (Trinei et al., 2009). Optimal levels of 
p66Shc phosphorylation were determined following testing a range of DOPPA 
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concentrations for 24 hours, followed by a time-course experiment. Initial analysis 
indicated that 25 nM and 50 nM DOPPA concentrations induced optimal phosphorylation 
of p66Shc following a 24 hour time exposure (Figure 3a). Further analysis revealed that 6 
hours of DOPPA exposure time produced the highest levels of phosphorylated p66Shc at 
both concentrations (25 and 50 nM) tested (Figure 3b). Thus, for all subsequent 
experiments, a 6 hour treatment with 50 nM DOPPA post-transfection was performed to 
ensure optimal p66Shc activation. 
 
3.3 p66Shc Activation increases Mitochondrial ROS Production 
Previous research using cells derived from p66Shc -/- mice revealed a significant 
decrease of intracellular ROS levels (Migliaccio et al., 1999). Therefore, it stands to 
reason that overexpressing p66Shc, and treating cells with a PKC-β agonist (DOPPA), 
should increase mitochondrial ROS levels. To examine changes in mitochondrial ROS 
production, control and treated cells were stained with MitoTracker® Red CM-H2XRos, 
a dye which localizes to mitochondria and fluoresces red in the presence of ROS. HT-22 
cells transfected with p66Shc-HA and treated with DOPPA displayed increased 
mitochondrial ROS when compared to either untreated p66Shc-HA or pcDNA3.1 
transfected cells (Figure 4A). Although previous data had suggested 6 hours of DOPPA 
treatment was effective for p66Shc phosphorylation, statistical analysis of mitochondrial 
ROS levels suggested the 6 hours of 50 nM DOPPA treatment was an insufficient time to 
significantly increase mitochondrial ROS levels (Figure 4A and 4B). However, 12 hour 
DOPPA time treatment did promote a significant (P<0.05) increase in ROS production in  
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Figure 2. Analysis of endogenous and ectopically expressed p66Shc levels in HT-22 
cells. HT-22 whole cell lysates were analyzed by Western blotting using a total Shc 
antibody (which recognizes all Shc isoforms) to compare endogenous (pcDNA) and 
ectopic (p66Shc, p66Shc-HA) expression of p66Shc. p66Shc (top band in center panel) 
was only detected in p66Shc and p66Shc-HA transfected cells. In addition, the blot was 
reprobed with an anti-HA specific antibody to specifically detect the HA-tagged p66Shc 
variant. An anti-Actin antibody was used as a loading control.   
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Figure 2 
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Figure 3. Optimization of p66Shc phosphorylation in HT-22 cells transfected with 
p66Shc expressing plasmids. (A) The effect of increasing concentrations of DOPPA 
(25, 50 and 100 nM) on p66Shc phosphorylation and expression levels over a 24 hour 
time period was assessed in pcDNA, p66Shc and p66Shc-HA transfected cells. (B) Time 
course of p66Shc expression and phosphorylation following DOPPA treatment (25 and 
50 nM) over 2, 6 and 24 hours in control (pcDNA) and p66Shc-HA transfected HT-22 
cells. Western blots were probed with antibodies that recognize serine-36 phosphorylated 
p66Shc (anti-P-Shc), all Shc isoforms (anti-TotalShc) and a loading control to ensure 
equal loading of protein samples across each treatment (anti-Actin). 
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Figure 3A 
 
Fi 
Figure 3B 
 
3.3 p66Shc phosphorylation induces increased levels of mitochondrial derived ROS 
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p66Shc-HA transfected cells compared to control and p66Shc transfected (non-treated) 
cells at the same time point (Figure 4B).   
 
3.4 p66Shc Activation Decreases Cell Viability 
 Studies have shown that knockout of the p66Shc gene increases longevity of mice 
by up to 30 percent, promoting both decreased ROS production and decreased cell death 
(Migliaccio et al., 1999). By this reasoning, overexpression of p66Shc should decrease 
cell viability after exposure to DOPPA in a time sensitive manner. A trypan blue 
exclusion test was performed to determine if p66Shc activation in HT-22 cells promotes 
decreased cell viability in accordance with other studies (Migliaccio et al., 1999). Indeed, 
HT-22 cell viability decreased significantly (P<0.05) over time in cells transfected with 
p66Shc-HA and treated with DOPPA (50 nM) at 12 and 24 hours, but not in cells 
transfected with an empty pcDNA3.1 vector and treated similarly as determined by One-
way ANOVA and Post-hoc TUKEY test (Figure 5). These results also revealed that 
DOPPA treatment for 12 hours provided the best timepoint for an increase in 
mitochondrial ROS production while the majority of cells still remained viable following 
p66Shc-HA activation. 
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Figure 4. Effect of p66Shc phosphorylation on mitochondrial ROS production in 
HT-22 cells. (A) Mitochondrial ROS levels (red fluorescence, as detected by 
MitoTracker® Red CM-H2XRos) in HT-22 cells transfected with pcDNA3.1 and 
p66Shc-HA plasmids and treated with 50 nM DOPPA for 6 and 12 hours. Nuclei were 
counterstained with Hoescht 33242 (blue fluorescence) and the two images were merged 
together. (B) MitoTracker® Red CM-H2XRos fluorescence was quantified using ImageJ 
software and statistically analyzed by One Way ANOVA and Post-hoc Tukey analysis. A 
significant increase (*, P<0.05) in mitochondrial ROS production was observed in 
p66Shc-HA transfected cells following 12 hours of DOPPA treatment compared to 
untreated or control cells.   
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Figure4A 
               
Figure4B   
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Figure 5. The effect of p66Shc-HA activation on cell viability in HT-22 cells. HT-22 
cells transfected with pcDNA or p66Shc-HA plasmids were exposed to DOPPA 
treatment (50nM) for various times and cell viability was assessed by trypan blue dye 
exclusion. At 12 and 24 hours a significant decrease in cell viability was observed in 
DOPPA treated p66Shc-HA transfected cells compared to the pcDNA control (*, 
P<0.05;**, P<0.01). 
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Figure 5 
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3.5 p66Shc mediated changes in the mitochondrial disulfide proteome 
 Once the optimal DOPPA concentration and exposure time for activation of 
p66Shc were determined, it was of interest to determine the effect of p66Shc activation 
on the disulfide proteome in both mitochondrial and cytosolic fractions. HT-22 cells were 
transfected with either pcDNA3.1 or p66Shc-HA vectors, and following 50 nM DOPPA 
treatment for 12 hours, cellular fractionation was performed using a commercial kit. The 
purity of mitochondrial fractions was verified by Western blotting using an anti-VDAC 
antibody, which recognizes the exclusively mitochondrial localized protein (Figure 6B). 
Once the purity of the mitochondrial samples were established, they were resolved by 
Redox 2D PAGE, followed by silver staining to reveal DSBPs that were altered in a 
p66Shc dependent manner. In silver stained gels, a prominent diagonal band appears in 
both the pcDNA (control) and p66Shc-HA resolved samples, and represents proteins that 
did not undergo disulfide bonding (Figure 6A). Of particular interest in this experiment, 
are the changes that occur to the off-diagonal spots, with spots to the right of the diagonal 
representing inter-molecular DSBPs and spots to the left of the diagonal representing 
intra-molecular DSBPs. Mitochondrial samples showed relatively few protein shifts 
representing change in DSBP status, however, three DSBPs appeared to be altered in 
p66Shc-HA samples compared to the pcDNA control samples (Figure 6A). Gels were 
repeated in triplicate to ensure consistency of results.   
 
3.6 Identifying mitochondrial-associated DSBPs altered with p66Shc expression 
The spots in the silver stained gels that exhibited shifted or changed staining 
intensity in p66Shc-HA samples were excised, digested with trypsin and identified by 
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matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry. The three mitochondrial inter-molecular DSBPs were identified as Lamin 
B1 (LMNB1), peroxiredoxin1 (PRXI) and eukaryotic translation elongation factor 1 
alpha (eEF1α1) (Table 1).    
 
3.7 Identification of Cytosolic DSBPs Altered with p66Shc Activation 
Changes in the disulfide proteome of the cytosolic fractions of HT-22 cells were 
also analyzed by Redox 2D-PAGE. As seen previously with Redox 2D PAGE analysis of 
mitochondrial fractions, a prominent diagonal band was also observed in the silver-
stained 2D gels with off-diagonal spots representing DSBPs. In contrast to mitochondria 
extracts, many more cytosolic inter- and intra-molecular DSBPs were detected by Redox 
2D-PAGE (Figure 7). However, only 5 DSBPs were reproducibly altered in p66Shc 
expressing HT-22 cells. MALDI-TOF MS analysis identified these proteins as 
tropomyosin-3 (TPM-3), aldo-keto reductase, moesin, radixin and adenylated cyclase 
associated protein 1 (CAP 1) (Table 2). 
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Figure 6. Ectopic p66Shc overexpression alters the mitochondrial disulfide 
proteome in HT-22 cells. HT-22 cells transfected with pcDNA and p66Shc-HA 
plasmids were treated with 50 nM DOPPA for 12 hours followed by subcellular 
fractionation to isolate mitochondria. Isolated mitochondria from both transfections were 
resolved by Redox 2D PAGE and silver stained to visualize proteins. A prominent 
diagonal band seen in both gels represent non-disulfide linked proteins, along with dark 
spots that appear off the diagonal regions which contain disulfide bonded proteins. 
Proteins that reproducibly appeared to undergo disulfide linkage following p66Shc 
overexpression and DOPPA treatment (50 nM) (spots 1-3, lamin B1, peroxiredoxinI and 
eukaryotic translation elongation factor 1 alpha 1, respectively) when compared to 
pcDNA transfected and DOPPA treated (50 nM) cells were identified by MALDI-TOF 
MS (Table 1). In the lower panel the purity of mitochondrial and cytosolic samples were 
verified by Western blot analysis using an antibody that recognizes the mitochondrial 
localized protein VDAC. VDAC protein was detected in mitochondrial, but not cytosolic 
fractions. Gel is representative of 3 separate experiments (N=3). 
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Figure 6 
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Table 1. Identification of mitochondrial disulfide linked proteins altered by p66Shc 
overexpression and DOPPA treatment (50 nM) in HT-22 cells. 
Spot 
No. 
Protein Presumed 
Location 
MOWSE 
Score 
Function Relative 
Change 
1 Lamin B1 Nuclear 
Mitochondria 
98 Nuclear Matrix 
Protein 
Increase 
2 Peroxiredoxin 1 Cytosol 
Mitochondria 
80 Antioxidant 
Enzymes 
Increase 
3 Eukaryotic 
translation elongation 
factor 1 alpha 1 
Cytosol 53 tRNA transfer/ 
Exports 
Nuclear 
Proteins 
Increase 
 
Mitochondrial DSBPs identified as unique to p66Shc-HA expressing HT-22 cells in 
Figure 6 were identified by MALDI-TOF MS. Peptide masses were searched in the NCBI 
RefSeq database, restricted to Mus musculus (house mouse) sequences, and MOWSE 
probability was calculated and expressed as -10logP. 
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Figure 7. Ectopic p66Shc overexpression alters the disulfide proteome in HT-22 
cytosolic fractions. HT-22 cells transfected with pcDNA and p66Shc-HA were treated 
with 50 nM DOPPA for 12 hours followed by cytosolic fractionation. Cytosolic protein 
extracts were resolved by redox 2D PAGE and silver stained to visualize proteins. A 
prominent diagonal band seen in both gels represents non-disulfide linked proteins, 
whereas dark spots that appear in off-diagonal regions contain intra- and inter-molecular 
disulfide bonded proteins. Proteins that reproducibly appeared to undergo disulfide 
linkage with p66Shc overexpression and DOPPA treatment (50 nM) (spots 1-5, 
tropomyosin-3, aldo-keto reductase, adenylated cyclase associated protein 1, moesin and 
radixin, respectively) when compared to DOPPA treated (50 nM) control (pcDNA) 
samples, were identified by MALDI-TOF MS (Table 2). In the lower panel the purity of 
cytosolic samples were verified by Western blot analysis using an antibody that 
recognizes the cytosolic protein actin. Gel is representative of 3 separate experiments 
(N=3). 
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Figure 7 
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Table 2. Identification of cytosolic disulfide linked proteins altered by p66Shc 
overexpression and DOPPA treatment (50 nM) in HT-22 cells. 
Spot 
No. 
Protein Location MOWSE 
Score 
Function Relative 
Change 
1 Troposmyosin 3 Cytosolic 130 Actin Binding/Cell 
Motility 
Increase 
2 Aldo-keto 
Reductase 
Cytosolic 98 NADPH-dependent 
oxidoreductases 
Increase 
3 CAP-adenylated 
cyclase-associated 
protein 
Cytosolic 82 Actin 
Remodeling/Cell 
Morphology 
Increase 
4 Moesin Cytosolic 76 Actin Binding/Cell 
Motility 
Increase 
5 Radixin Cytosolic 52 Actin Binding/Cell 
Motility 
Increase 
 
Alterations in disulfide linked proteins within HT-22 cytosolic samples as a result of 
p66Shc overexpression (Figure 7) were determined by MALDI-TOF MS. Protein 
sequences were BLAST searched and Peptide masses were searched in the NCBI RefSeq 
database, restricted to Mus musculus (house mouse) sequences, and MOWSE probability 
was calculated and expressed as -10logp. 
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3.8 p66Shc overexpression affects the redox status of Tropomyosin-3 in the cytosol 
 Redox 2D PAGE analysis of HT-22 cytosolic samples identified a number of 
actin binding proteins, including tropomyosin-3 (TPM-3), that were affected by p66Shc 
expression and phosphorylation. Therefore, a non-reducing/reducing 1D SDS PAGE was 
performed to detect a shift in TPM-3 molecular weight indicating a change in oxidation 
status. Proteins that form intermolecular disulfide bonds exhibit slower electrophoretic 
migration and therefore appear as higher molecular weight (HMW) bands compared to 
the fully reduced monomeric form of the protein (Cumming et al., 2004). HT-22 
cytosolic samples were resolved by both non-reducing and reducing 1D-PAGE and 
electroblotted onto PVDF. Blots were then probed with an anti-TPM-3 antibody to detect 
changes in TPM-3 disulfide bonding. P66Shc-HA expression promoted increased 
disulfide linked HMW forms of TPM-3 of approximately 80-90 kDa that were not 
apparent in the pcDNA control transfected cells (Figure 8). In addition, activation of 
p66Shc by DOPPA treatment further promoted increased TPM-3 disulfide linkage. In 
contrast, reducing 1D SDS PAGE analysis revealed that overall monomeric (~33 kDa) 
TPM-3 levels remain relatively constant across all treatments (Figure 8).  
 
3.9 Changes in Filamentous Actin organization following p66Shc overexpression  
 TPM-3 is a non-muscle tropomyosin isoform that forms coiled-coil dimers that 
bind along the length of actin filaments thereby affecting cytoskeletal dynamics and cell 
migration (Lin, Eppinga, Warren, & McCrae, 2008). Radixin and moesin (part of the 
ERM family of proteins) associate with the actin cytoskeleton and plasma membrane 
adhesion complexes and control a variety of cellular processes including cell 
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morphogenesis, migration, proliferation and survival (Fehon, McClatchey, & Bretscher, 
2010). CAP1 is a bifunctional protein with an N-terminal domain that binds to Ras-
responsive adenyl cyclase and a C-terminal domain that inhibits actin polymerization and 
is important for cell morphology, migration and endocytosis (Hubberstey & Mottillo, 
2002). In light of the fact that all of these proteins interact with and affect actin 
polymerization, and exhibit changes in disulfide linkage following p66Shc activation, it 
was therefore of interest to examine filamentous (F-actin) structures in HT-22 cells. 
  To examine changes in F-actin structure associated with p66Shc-HA activation, 
control (pcDNA 3.1) and experimental (p66Shc-HA) transfected HT-22 cells were treated 
with 50 nM DOPPA (NT, 6hrs, 12hrs), fixed, and stained with TRITC conjugated 
phalloidin. Phalloidin is a molecule that binds F-actin and conjugated TRITC allows for 
visualization by fluorescence microscopy. Staining revealed qualitative differences in F-
actin structure between control and p66Shc-HA transfected cells (Figure 9). Notable 
changes in HT-22 cells expressing activated p66Shc-HA included a decrease in cortical 
actin filaments and the accumulation of peri-nuclear actin aggregates (Figure 9). It is 
unclear if ectopically expressed p66Shc-HA promotes alterations in F-actin through 
direct interaction or if changes are occurring as a result of p66Shc mediated 
mitochondrial ROS production. However, these results suggest that p66Shc expression 
and phosphorylation either directly or indirectly lead to detrimental alterations in HT-22 
F-actin dynamics.  
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Figure 8. Overexpression of p66Shc-HA promotes increased disulfide linkage of 
cytosolic Tpm-3. Cytosolic extracts from pcDNA and p66Shc-HA transfected cells were 
resolved by non-reducing and reducing 1D SDS PAGE followed by immunoblot analysis 
using an anti-TPM3 antibody. HT-22 cells overexpressing p66Shc exhibited disulfide 
linked HMW forms of TPM-3 (~80 and 90 kDa) that were further increased following 
DOPPA treatment (arrows). Control cells transfected with pcDNA3.1 did not display the 
HMW disulfide-linked TPM-3 species in either the presence or absence of DOPPA 
exposure.   HT-22 cytosolic fractions exposed to reducing agents displayed relatively 
equal levels of monomeric (33 kDa) TPM-3 in both pcDNA and p66Shc-HA transfected 
cells (arrowhead).  
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Figure 8 
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Figure 9. p66Shc activation in HT-22 cells promotes alterations in F-actin consistent 
with altered disulfide bonding of cytoskeletal regulators. HT-22 cells transfected with 
p66Shc-HA combined with DOPPA (50 nM) treatment exhibited peri-nuclear F-actin 
aggregates (arrows), that were absent in control transfected cells treated with DOPPA (C, 
E). In addition, p66Shc-HA transfected (B, D, and F) displayed a decrease in cortical 
actin filaments and leading edge lamellipodia structures that became more pronounced 
with DOPPA exposure. Arrows indicate peri-nuclear accumulations of F-actin in panels 
D and F, while arrowheads indicate change in cortical actin filaments and leading edge 
lamellipodia structures (D and F) associated with p66Shc-HA transfection and DOPPA 
exposure. 
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Figure 9 
 
 
 
 
 
 
 
 
 
 
 
A B 
C D 
E F 
_____ 
50 µm 
T. Cann Thesis  48 
 
Chapter 4 
Discussion and Future Research 
 
 
4.1 Overview 
 The observation that p66Shc-/- mice show significantly decreased intracellular 
ROS levels and increased longevity is an intriguing finding, but the molecular 
mechanisms underpinning this novel phenotype is poorly understood (Migliaccio et al., 
1999) In this study, I sought to determine the effects of p66Shc expression on the 
disulfide proteome in both the mitochondria and cytoplasm of HT-22 cells. These two 
subcellular regions were investigated separately in hopes of identifying changes in the 
disulfide proteome that may be associated with redox-regulated pathways or apoptotic 
responses affected by p66Shc activation. The findings presented here suggest that 
mitochondrial DSBPs altered by p66Shc activation appear to be proteins that are 
traditionally found elsewhere in the cell and may localize to mitochondria through some 
kind of stress response mechanism. Furthermore, proteins identified to undergo altered 
disulfide bonding in the cytoplasm in a p66Shc-dependent manner are associated with F-
actin and participate in cytoskeleton remodeling.  
 
4.2 Overexpressing p66Shc increases ROS and decreases cell viability 
 The observed increase in mitochondrial ROS production occurred in p66Shc-HA 
transfected HT-22 cells treated with PKC-β agonist DOPPA (50 nM) for 12 hours. The 
increase in mitochondrial ROS production appears to be directly related to the expression 
and phosphorylation of p66Shc. These results are in accordance with previous p66Shc 
overexpression experiments performed in various mouse fibroblast and hepatocyte cells 
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whereby p66Shc serine phosphorylation was induced by H2O2 treatment (Giorgio et al., 
2005; Nemoto et al., 2006). As previously discussed, p66Shc participates in redox 
processes and once translocated into the mitochondrial IMS, can accept electrons from 
cytochrome c (Gertz et al., 2008; Giorgio et al., 2005). However elevated p66Shc levels 
in the mitochondrial IMS are believed to decrease the efficiency of electron transport 
within the ETC and promote the formation of O2¯  and H2O2 (Giorgio et al., 2005; Pinton 
& Rizzuto, 2008). The increase in p66Shc mediated mitochondrial ROS is believed to be 
critical for induction of apoptosis (Migliaccio et al., 1999). These findings suggest that 
elevated ROS precedes cell death in the HT-22 cell model and the time-delay may be due 
to redox-dependent signaling processes that need to occur before initiation of cell death.   
 
4.3 p66Shc mediated alterations in the mitochondrial disulfide proteome 
 Recent studies have indicated that oxidation of protein thiol groups within the 
mitochondrial IMS may affect cellular functions such as apoptosis and ROS homeostasis 
(Herrmann & Riemer, 2010). Based on previous research highlighting the ROS 
promoting effects of p66Shc in the mitochondrial IMS, I analyzed the disulfide proteome 
in isolated mitochondria from p66Shc-HA transfected HT-22 cells. This was not an easy 
endeavour since isolating mitochondria in vitro requires a large number of cells and extra 
caution as pelleted mitochondria are barely visible during fractionation. However, enough 
mitochondria were eventually isolated to resolve DSBPs via Redox 2D SDS PAGE and 
identify three proteins (Lamin B1 (LMNB1), Peroxiredoxin I (PRXI), Eukaryotic 
translation elongation factor 1 alpha 1 (eEF1α1)) that were altered with p66Shc 
activation. Interestingly, the localization of LMNB1 and PRXI to the mitochondria is of 
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particular interest because under normal conditions these proteins are usually found in the 
nucleus and cytosol, respectively. 
4.3.1 Lamin B1  
 The identification of LMNB1 as a disulfide altered protein found localized to the 
mitochondria may provide a significant clue to the stress response initiated by p66Shc 
activation. LMNB1 is a nuclear matrix protein that is normally associated with 
maintaining nuclear structure and chromatin stability (Tu et al., 2012). However, recent 
studies suggest that under stress conditions, LMNB1 may localize to the mitochondria 
and play a role in apoptotic pathways (Tu et al., 2012). In a study testing the liposomal 
sodium morrhuate treatment of infantile hemangioma endothelial cells, LMNB1 was 
shown to localize to the mitochondria and be implicated in the activation of apoptotic and 
necrotic pathways in exposed infantile hemangioma endothelial cells (Tu et al., 2012). 
Interestingly, a recent study revealed that Lamin B2 (LMNB2) in cultured Xenopus 
retinal ganglion cell neurons is synthesized in close proximity to mitochondria in axons 
in response to guidance cue stimulation (Yoon et al., 2012). In addition, loss of axonal 
LMNB2 leads to mitochondria dysfunction and axon degeneration independently from 
the cell body. Furthermore, LMNB1 was suggested to play a role in necrosis and 
apoptosis in mouse cancer cell lines. An upregulation of the nuclear matrix protein was 
observed during 5-fluoro-2-deoxyuridine induced necrosis and apoptosis, prompting the 
authors of this study to speculate that LMNB1 may play a role in regulating cell death 
(Sato et al., 2009). The specific role of LMNB1 in regulating nerve cell function, cell 
morphology and apoptosis is not certain; however the research shown here suggests a 
change in the disulfide-linked state of LMNB1, mediated by a p66Shc-associated ROS 
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increase, may be responsible for initiating the localization of LMNB1 to the 
mitochondria.  
 
4.3.2 Peroxiredoxin I 
 The identification of PRXI as a disulfide-linked protein in p66Shc overexpressing 
HT-22 mitochondrial fractions was of interest. Peroxiredoxins (PRXs) function as anti-
oxidant enzymes that detoxify peroxides and are regulated by changes in 
phosphorylation, redox status and oligomerization states (Wood et al. 2003). PRXs are 
ubiquitously expressed with various isoforms localized to different subcellular 
compartments. In mammalian cells, there are 6 different PRX isoforms. PRXI is 
generally found in the cytoplasm while PRXIII is localized to the mitochondria (Fujii & 
Ikeda, 2002). Interestingly, a disulfide-linked form of PRXI was found in isolated 
mitochondria from HT-22 cells expressing activated p66Shc (Figure 6, spot 1).  One 
possible explanation for this occurrence may relate to the activity of sulfiredoxin (SRX), 
an enzyme that catalyzes the reduction of cysteine sulfonic acids to an active thiol form. 
SRX has been shown to interact with and reduce PRXI in the cytosol, and can also 
translocate into the mitochondria to reduce hyper-oxidized PRXIII as an anti-apoptotic 
defense (Noh, Baek, Jeong, Rhee, & Chang, 2009). Therefore, the interaction of PRXI 
and SRX along with the localization of SRX to mitochondria under a stress response 
could potentially influence localization of PRXI to mitochondria; however this idea 
awaits further investigation. Interestingly, in a recent study PRXI was shown to interact 
with p66Shc in the cytoplasm (Gertz et al., 2009). Interaction with PRXI leads to a 
reduction in p66Shc tetramer formation, which reduces its ability to induce mitochondrial 
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apoptosis (Gertz et al., 2009). It is uncertain if p66Shc interacts with and affects the 
activity of PRXI in the mitochondrial IMS, but this line of investigation is worth pursuing 
in future studies.  
4.3.3 Eukaryotic Elongation Factor 1 Alpha 1 
 eEF1α1 was originally selected as control spot, as its location on the prominent 
diagonal band in redox 2D PAGE gels suggests it may not undergo alterations in DSB 
status. eEF1α1 is a subunit in the elongation factor-1 complex, which delivers aminoacyl 
tRNAs to the ribosome (Khacho et al., 2008). Although it was identified through MS, a 
change in DSB status of eEF1α1 could not be unequivocally confirmed due to its close 
proximity to the diagonal line of the gel (Figure 6).  
 
4.4 p66Shc Mediated Alterations on the Cytosolic Disulfide Proteome 
 In this study, four cytosolic DSBPs were shown to be influenced by p66Shc 
activation and are known to associate with F-actin (Amieva & Furthmayr, 1995). Moesin, 
radixin, adenylated cyclase-associated protein 1 (CAP1) and tropomyosin-3 (TPM-3) are 
well known to interact with the actin cytoskeleton and influence cell morphology and 
motility (Bryce et al., 2003). The altered DSB status of these proteins likely arise as a 
downstream result of p66Shc activation and the associated ROS production Proteins 
associated with the actin cytoskeleton can have a great impact on the form and function 
of cytoskeleton dynamics (Bryce et al., 2003). 
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4.4.1 Moesin and Radixin 
Moesin and radixin are generally associated with fillipodia, located at the leading edge of 
cell motility and is part of the ERM protein family (along with erzin)(Lankes & 
Furthmayr, 1991). Moesin and radixin function as a link between the actin cytoskeleton 
and plasma membrane, and have been implicated in cell spatial recognition and cell 
signaling (Lankes & Furthmayr, 1991). Moesin and radixin are suggested to have a key 
role in the formation of tiny projections outward from fillipodia, and detect cell signals 
through chemotaxis. The association of moesin and radixin with F-actin is suggested to 
be important for relaying signals concerning the extracellular matrix and other cells 
(Lankes & Furthmayr, 1991). The results presented here are the first to suggest that both 
proteins undergo disulfide bonding in response to elevated ROS. 
 
4.4.2 Cyclase Associated Protein 1 (CAP1)  
Cyclase associated protein 1 (CAP1) has been implicated in signaling related to 
filamentous actin polymerization in mammals (Hubberstey & Mottillo, 2002). CAPs 
possess a conserved C-terminus motif that allow interaction with filamentous actin, while 
the N-terminus is specified for signal relay (Hubberstey & Mottillo, 2002). Recent 
research has suggested that CAPs are necessary for quick depolymerisation of F-actin. 
CAP1 may also augment cofilin function and effectively increase the speed of F-actin 
depolymerisation (Normoyle & Brieher, 2012). An alteration to the disulfide status of 
moesin, radixin and CAP1 could have large implications in dynamic cytoskeleton 
remodelling, cell movement and cell signaling. 
 
T. Cann Thesis  54 
 
4.4.3 Tropomyosin-3 
Tropomyosin-3 (TPM-3) was a cytoskeleton DSBP that had the highest MOWSE 
sequence probability match of all the proteins identified (Table 2). TPM-3 plays an 
important role in actin dynamics as its primary role is to bind F-actin and inhibit access to 
catalytic sites in the major groove (Bryce et al., 2003). Although the specific interactions 
of TPM-3 in non-muscle cell actin stabilization are not as well understood as in muscle 
cells, studies suggest that TPM-3 provides a balance against competitor proteins such as 
cofilin and Arp 2/3 to help stabilize actin dynamics (DesMarais et al. 2005). A change in 
the DSB status of TPM-3 may alter protein function so that TPM-3 becomes more tightly 
bound to F-actin thereby causing it to become rigid and vulnerable to disorganization 
(Chountala, Vakaloglou, & Zervas, 2012). The functionality of TPM-3 relies heavily on 
its ability to dimerize through the formation of a disulfide bridge between centrally 
located cysteine residues, which may be controlled through a change in redox status 
(Hegmann, Lin, & Lin, 1988). 
 
4.5 Non-reducing/Reducing Behaviour of Tpm-3 in p66Shc Expression Samples 
The accumulation of oxidized TPM-3 in p66Shc expressing HT-22 cells suggests that 
stabilization of its dimerized form, effectively renders F-actin in a more rigid state (Mello 
et al., 2007). As previously mentioned, the dynamic nature of filamentous actin is crucial 
to several intracellular functions, including cell structure and motility, cell signaling, 
intracellular transport, endocytosis and compartmentalization of subcellular organelles 
(Halpain, 2003). Inhibition of actin dynamics can potentially lead to a disorganization of 
filamentous actin triggering stress responses and apoptosis as seen in Drosophila when 
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overexpressing the actin-binding protein parvin (Chountala et al., 2012). The changes in 
DSB status of actin binding proteins may help to mediate apoptotic events associated 
with p66Shc expression and serine phosphorylation. Increases in mitochondrial ROS 
formation appear to act downstream of the mitochondria, affecting actin dynamics 
through redox signaling, and effectively disrupting several important cell functions.  
4.6 Cytoskeleton Structure changes with Cytosolic DSBP Alterations 
 With the identification of five actin binding proteins undergoing disulfide 
alterations in the cytosol of cells expressing activated p66Shc, I turned my attention to 
how the changes in DSB status of these proteins affects F-actin structure. Before staining 
for F-actin, I noticed changes in cell morphology in other p66Shc transfection + DOPPA 
experiments such as mitoTracker® ROS and trypan blue exclusion experiments. The 
natural, stellate morphology of HT-22 cells was replaced by a more rounded cell 
morphology. Staining control and p66Shc-HA transfected HT-22 cells +/- DOPPA (50 
nM) with phalloidin-TRITC to visualize F-actin, revealed several abnormalities in F-actin 
related to p66Shc activation. Phalloidin staining revealed disorganization of actin 
filaments, peri-nuclear actin accumulation, a decrease in cortical actin filaments and 
disruption of lamellipodia (Figure 9B, 9D, 9F). These effects are unlikely to arise from 
DOPPA treatment as control cells transfected with pcDNA3.1 plasmid and treated with 
DOPPA (50 nM) displayed F-actin staining consistent with healthy motile cells (Figure 
9A, C, E). 
These results suggest that alterations in disulfide bonding of actin regulators may 
affect F-actin polymerization in a number of ways. Firstly, disorganized F-actin may 
occur as a result of an increased affinity of the oxidized dimeric form of TPM-3 for actin. 
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Previous studies have shown that overexpression of an oxidized dimeric isoform of Tm 
(Tm5NM1) produces a disorganized cytoskeleton in mesenchymal cells in a similar 
manner to the results seen with HT-22 cells (Lees et al., 2011). Altered F-actin dynamics 
as a result of tighter binding by TPM-3 may render the actin cytoskeleton vulnerable to 
disorganization events (Chountala et al., 2012). It has been suggested that elevated 
binding of TPM-3 to F-actin under stress conditions may be part of a cellular ATP 
conservation mechanism (Bernstein, Chen, Boyle, & Bamburg, 2006). ATP conservation 
under stress conditions is suggested to divert ATP to more essential cellular processes. 
Furthermore, increased disulfide linkage of CAP1 could not only have implications for F-
actin related signaling, but also with F-actin polymerization dynamics. Recent studies 
suggest that CAPs accelerate cofilin mediated F-actin depolymerisation (Normoyle & 
Brieher, 2012).  
Alterations in both TPM-3 and CAP1 DSB status may be working in concert with 
one another, using redox signaling as a stress sensor to trigger a response to p66Shc 
mediated ROS. Downstream ROS accumulation in response to p66Shc activation could 
also be responsible for the observed peri-nuclear accumulation of F-actin. The observed 
peri-nuclear localization of F-actin may be the formation and accumulation of cofilin-
actin rods that form under stress conditions (Munsie, Desmond, & Truant, 2012). Under 
the same ATP diversion mechanisms mentioned earlier, cofilin and actin are shuttled out 
of the nucleus in a rod-like state under stress conditions. Cofilin-actin rods function to 
prevent actin from polymerizing into new filaments and using valuable ATP (Munsie et 
al., 2012). 
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 The visible change in F-actin stability at the leading edge in HT-22 cells 
expressing activated p66Shc may be caused, at least in part, by disulfide linkage of 
moesin and radixin. Moesin is generally highly localized within filopodia and function as 
cross-linkers between the plasma membrane and F-actin cytoskeleton (Lankes & 
Furthmayr, 1991). Alterations in the DSB status of moesin and radixin could inhibit its 
function and compromise structures associated with the leading edge of the cell 
associated with actin dynamics, microprojections, cell movement and morphology 
(Amieva & Furthmayr, 1995). Future studies will focus on the effect of disulfide-linkage 
of these actin binding proteins on cell morphology and migration in response to p66Shc 
activation. 
 
4.7 Conclusions 
 The research presented provides new insight into the effects of p66Shc mediated 
ROS on the disulfide proteome within the mitochondria and cytosolic. Previous research 
demonstrated that p66Shc promotes increased intracellular ROS levels and apoptosis in 
response to serine-36 phosphorylation. However, potential redox mechanism(s) 
associated with p66Shc mitochondrial ROS accumulation and the downstream effects on 
protein redox status are poorly understood. Using an HT-22 mouse hippocampal 
neuronal-like cell line as an experimental model, p66Shc-HA was ectopically expressed 
and phosphorylation induced by the PKC-β agonist DOPPA. Alterations in the disulfide 
proteome of mitochondrial and cytosolic fractions were investigated to determine the 
effects of p66Shc mediated ROS on redox regulated processes in search of clues 
pertaining to the role of p66Shc in longevity. Increased levels of mitochondrial ROS 
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mediated by p66Shc activation affect the DSB status of LMNB1 and PRXI in HT-22 
mitochondrial subcellular fractions. Localization of these two proteins to the 
mitochondria was surprising as these proteins are normally associated with the nuclear 
matrix and cytosol respectively. However, previous research suggests that LMNB1 may 
localize to the mitochondria as part of a stress response to promote activation of apoptotic 
pathways. I speculate that PRXI mitochondrial localization may be due to the 
translocation of SRX from the cytosol to the mitochondrial IMS under mitochondrial 
stress conditions. As previously mentioned SRX is an oxireductase that functions to 
maintain PRX in an active reduced state, with the ability to interact with both PRXI in the 
cytosol and translocate to associate with mitochondrial PRXIII. In addition, PRXI have 
been shown to interact with and inhibit p66Shc activation in the cytosol. Changes in DSB 
status of LMNB1 and PRXI could facilitate their localization to the mitochondria by a 
p66Shc dependent process. 
 Moesin, radixin, TPM-3, and CAP1 were all identified as cytosolic proteins that 
underwent altered disulfide bonding in response to p66Shc activation. In light of the role 
these proteins play in F-actin dynamics, these results are significant in the search for 
clues regarding p66Shc’s role in longevity. Changes in redox status of these cytoskeletal 
proteins may signal a cascade of changes to F-actin dynamics and conservation of ATP in 
an attempt to counter p66Shc mediated perturbations of mitochondrial activity and ROS 
production. My research suggests that p66Shc may elicit a stress response by promoting 
altered disulfide bonding of proteins implicated in cytoskeletal remodeling and by 
facilitating the localization of disulfide-linked apoptotic proteins to the mitochondria.    
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